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Using mutability landscapes of a promiscuous
tautomerase to guide the engineering of
enantioselective Michaelases
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The Michael-type addition reaction is widely used in organic synthesis for carbon–carbon
bond formation. However, biocatalytic methodologies for this type of reaction are scarce,
which is related to the fact that enzymes naturally catalysing carbon–carbon bond-forming
Michael-type additions are rare. A promising template to develop new biocatalysts for
carbon–carbon bond formation is the enzyme 4-oxalocrotonate tautomerase, which exhibits
promiscuous Michael-type addition activity. Here we present mutability landscapes for the
expression, tautomerase and Michael-type addition activities, and enantioselectivity of
4-oxalocrotonate tautomerase. These maps of neutral, beneﬁcial and detrimental amino acids
for each residue position and enzyme property provide detailed insight into sequence–
function relationships. This offers exciting opportunities for enzyme engineering, which is
illustrated by the redesign of 4-oxalocrotonate tautomerase into two enantiocomplementary
‘Michaelases’. These ‘Michaelases’ catalyse the asymmetric addition of acetaldehyde to
various nitrooleﬁns, providing access to both enantiomers of g-nitroaldehydes, which are
important precursors for pharmaceutically active g-aminobutyric acid derivatives.
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C
hiral g-nitroaldehydes are valuable precursors for
pharmaceutically active GABA (g-aminobutyric acid)
derivatives. For example, marketed pharmaceuticals
Phenibut (anxiolytic), Pregabalin (anticonvulsant), Baclofen
(muscle relaxant) and Rolipram (antidepressant) can be readily
obtained from distinct chiral g-nitroaldehydes by two simple
chemical steps1,2. Preparation of the appropriate g-nitroaldehyde
precursors for these GABA derivatives would require the
Michael-type addition of acetaldehyde to diverse nitroalkene
acceptors. The Michael-type addition of unmodiﬁed aldehydes to
nitroalkenes has recently become viable by the development
of proline- and peptide-based organocatalysts3–5. However,
examples including acetaldehyde as donor substrate are scarce
and 10–20mol% of organocatalyst in organic solvent is typically
applied4–9. Therefore, there is great interest in the development
of alternative biocatalytic procedures for the enantioselective
synthesis of g-nitroaldehydes. Unfortunately, enzymes that
naturally catalyse carbon–carbon bond-forming Michael-type
additions are extremely rare10. A few elegant studies on
promiscuous enzyme-catalysed carbon–carbon bond-forming
Michael-type additions have been reported; however, most of
these reactions proceed in organic solvent with low or moderate
stereocontrol and do not involve acetaldehyde as donor
substrate11–18.
The enzyme 4-oxalocrotonate tautomerase (4-OT) is composed
of six identical subunits of only 62 amino acid residues each19,20.
It belongs to the tautomerase superfamily, a group of homologous
proteins that share a unique catalytic amino-terminal proline
(Pro-1) and a characteristic b-a-b structural fold21–23. 4-OT takes
part in a catabolic pathway for aromatic hydrocarbons in
Pseudomonas putida mt-2 (Fig. 1a), where it catalyses the
tautomerization of 2-hydroxymuconate (1) to yield 2-oxohex-3-
enedioate (2)24. Residue Pro-1 functions as a general base
(pKaE6.4) that transfers the 2-hydroxyl proton of 1 to the
C5-position to give 2 (ref. 25). Two other key catalytic residues
are Arg-11 and Arg-39. Arg-39 is proposed to interact with the
2-hydroxyl group of 1 and a C-1 carboxylate oxygen, whereas
Arg-11 is proposed to interact with the C-6 carboxylate group
in a bidentate manner26. The latter interaction may draw
electron density towards C-5 to facilitate protonation by Pro-1
(refs 21,26,27).
Inspired by the versatile success of proline and its derivatives as
organocatalysts, we anticipated and found the proline-based
enzyme 4-OT to promiscuously catalyse carbon–carbon
bond-forming reactions such as aldolizations and Michael-type
additions28–31. These include Michael-type additions of linear
aldehydes, such as acetaldehyde (3) or butanal (4) (Fig. 1b),
to a variety of nitroalkenes (5a–5g) to yield enantioenriched
g-nitroaldehydes (6a–6g and 7), which are important precursors
for GABA analogues such as the above-mentioned
pharmaceuticals31. The proposed catalytic mechanism involves
formation of an enamine intermediate of the aldehyde donor with
the active site Pro-1 residue of 4-OT, reminiscent of the
mechanism of proline-based organocatalysts28,32.
The discovery of the promiscuous Michael-type addition
activity of 4-OT is an important step on the way to develop
new biocatalysts for synthetically useful Michael-type reactions.
Accordingly, it would be very attractive to enhance the
Michael-type addition activity of 4-OT and improve its
enantioselectivity. Because of the strong advantage of working
with a protein with a small monomer size, we describe herein the
construction of entire mutability landscapes for the expression,
tautomerase and Michael-type addition activities, and enantio-
selectivity of 4-OT. These landscapes may be assessed and






















5a: R2 = Ph
5b: R2 = p-Cl-C6H4
5c: R2 = p-F-C6H4
5d: R2 = p-HO-C6H4
5e: R2 = 3-HO-4-MeO-C6H3
5f: R2 = 3-c-PentO-4-MeO-C6H3
5g: R2 = isobutyl
3: R1 = H
4: R1 = Et
6a: R1 = H, R2 = Ph
6b: R1 = H, R2 = p-Cl-C6H4
6c: R1 = H, R2 = p-F-C6H4
6d: R1 = H, R2 = p-HO-C6H4
6e: R1 = H, R2 = 3-HO-4-MeO-C6H3
6f:  R1 = H, R2 = 3-c-PentO-4-MeO-C6H3
6g: R1 = H, R2 = isobutyl







Figure 1 | Natural and promiscuous reactions catalysed by 4-OT. (a) 4-OT-catalysed tautomerization of 2-hydroxymuconate (1) to yield 2-oxohex-3-
enedioate (2) as part of a degradative pathway for aromatic compounds. (b) 4-OT-catalysed Michael-type additions of acetaldehyde (3) or butanal (4) to
nitroalkenes 5a–5g to give g-nitroaldehydes 6a–6g or 7. (c) 4-OT-catalysed tautomerization of phenylenolpyruvate (8) to yield phenylpyruvate (9).
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reasoned about as a whole, providing detailed insight into
sequence–function relationships. Simultaneously, intelligent
mutability-landscape navigation, coupled to combinatorial
mutagenesis, offers exciting opportunities for rapid enzyme
engineering33,34. This is illustrated here by the generation of
4-OT variants with improved activity and enantioselectivity, as
well as inverted enantioselectivity, in Michael-type additions. The
usefulness of these designer ‘Michaelases’ is demonstrated by
their application in the asymmetric addition of acetaldehyde to
various nitroalkenes, providing convenient access to both
enantiomers of chiral g-nitroaldehydes, which are valuable
precursors for GABA derivatives, several of which represent
marketed pharmaceuticals.
Results
Collection of single 4-OT mutants. To chart the mutability
landscapes of 4-OT, a collection of 4-OT genes encoding nearly
all possible single variants of 4-OT was constructed. This unique
collection covered at least 15 of the 19 possible variants at each
residue position, from Ile-2 to the carboxy-terminal Arg-62.
Single mutants of the N-terminal proline residue (Pro-1) were not
included in the collection, because Pro-1 is a key catalytic residue
and mutations at this position lead to incorrect demethionylation
of the protein35,36. The 4-OT genes did not contain any afﬁnity
tag and were individually cloned, stored and expressed in
Escherichia coli BL21(DE3). Importantly, as all 4-OT variants
are stored and analysed separately, no oversampling is required.
Mutability landscape of 4-OT for protein expression. A
mutability landscape for protein expression was generated by
determining the effect of each mutation on the production of
soluble 4-OT protein. From the alignment of this landscape with
the secondary structure elements of 4-OT (Fig. 2), it becomes
apparent that many mutations in the a1-helix result in decreased
production of soluble protein. Most notably, the introduction of a
proline residue at any given position in the a1-helix has a
pronounced effect on soluble 4-OT production. It seems likely to
be that the introduction of a proline disrupts this a1-helix,
resulting in an insoluble 4-OT mutant. The b-hairpin element
(Gly-51 to Leu-56) is thought to play a crucial role in the stabi-
lization of the hexameric structure of 4-OT20,21. Although most
mutations in this region do not seem to affect the amount of
soluble protein produced, replacing the negatively charged Glu-55
with a positively charged residue (Lys or Arg) decreases the
amount of soluble 4-OT protein produced to a level that is below
the detection limit. The average effect of each amino acid
substitution on the amount of soluble protein produced reveals
that substitutions to Trp, Arg and Pro are the most unfavourable
ones (Fig. 2b). A probable explanation for this is that these
residues have the biggest impact on the protein structure because
of their volumetrically large side chain, charge or conformational
rigidity, respectively. The ﬁnding that these amino acid
substitutions are highly unfavourable for soluble protein
production is consistent with the results of a recently published
systematic mutagenesis study on a protein-binding domain37. On
the other hand, some mutations seem to increase the amount of
soluble protein produced. These mutations can be found mainly
at positions His-6, Ile-7 and Lys-47. Gratifyingly, the majority of
the mutants was produced in sufﬁcient amounts to enable activity
assays.
Mutability landscape of 4-OT for tautomerase activity.
A mutability landscape for the tautomerase activity of 4-OT was
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Figure 2 | Mutability landscape of 4-OT for protein expression. (a) The horizontal axis of the data matrix depicts the wild-type sequence of 4-OTand the
vertical axis depicts the 20 possible amino acid residues. The wild-type amino acid residue at each position is indicated by bold squares and white boxes
represent mutants that are not present in the collection. The colour indicates the concentration of soluble 4-OT variants in CFE in mgml 1, which was
determined by quantitative densitometry on SDS–PAGE gels (Supplementary Fig. 1; details on this procedure can be found in the Methods section).
The detection limit of this method is 0.5mgml 1. The depicted data are an average of two separate experiments (n¼ 2). (b) The average effect of
each amino acid substitution across the entire protein on the expression of soluble protein. (c) The secondary-structure elements of 4-OT20.
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ability of the enzyme to ketonize phenylenolpyruvate (8) to
phenylpyruvate (9) (Fig. 1c). Screening assays with the native
substrate of 4-OT, 2-hydroxymuconate (1), were not possible due
to the high activity (kcatB3500 s 1) of the enzyme with this
substrate38. Hence, activity proﬁling required very low enzyme
concentrations, probably leading to hexamer dissociation,
yielding unreproducible results. Therefore, the alternative
substrate 8 (kcat¼ 73 s 1) was used to monitor the tautomerase
activity of 4-OT, which enabled a practical screening assay with
reproducible results39.
The mutability landscape for 4-OT’s tautomerase activity
demonstrates the mutational robustness of the enzyme for this
activity (Fig. 3a). This is apparent from mutations in various
regions of the enzyme that show no or little effect on activity,
including the regions Ser-12 to Arg-29 and Gly-54 to Arg-62.
It has been hypothesized that such neutral mutations can have an
important role in natural enzyme evolution, because they may
result in ‘neutral drift’40–42. Whitman and colleagues26,27
demonstrated that the two active-site arginines (Arg-11 and
Arg-39) of 4-OT are required for the tautomerization of
dicarboxylate substrates, because they interact with the
carboxylate moieties of the substrate. Fully consistent with this
ﬁnding, we observed that only one active-site arginine (Arg-11) is
essential for the tautomerization of the monocarboxylate
substrate 8. In addition to Arg-11, also Gly-10 appears to be
important for the tautomerase activity. As mutations at Gly-10
have no signiﬁcant effect on enzyme expression (Fig. 2), it is
unlikely to be that this residue is required for correct overall
folding of the enzyme. It is therefore tempting to speculate that
this residue is required for securing the correct architecture of the
active site.
Interestingly, ﬁve positions at which single mutations result in
signiﬁcantly improved tautomerase activity (45-fold) were
identiﬁed. These include mutations at positions Ile-2, Gln-4,
Leu-8, Ser-37 and Phe-50. Whereas Ile-2, Leu-8, Ser-37 and Phe-
50 are lining the Pro-1 pocket, the distance between Gln-4 and
Pro-1 isB11Å, illustrating that both close and distant mutations
can improve activity43. These ﬁndings suggest that 4-OT could be
readily engineered to become a more efﬁcient catalyst for the
tautomerization of 8.
Mutability landscape of 4-OT for the addition of 3 to 5a. To
generate a mutability landscape for the promiscuous ‘Michaelase’
activity of 4-OT, the effect of each mutation on the ability of the
enzyme to catalyse the addition of acetaldehyde (3) to trans-b-
nitrostyrene (5a) was determined. This activity was monitored
(using ultraviolet spectroscopy) by following the depletion of
substrate 5a in the presence of 3 and enzyme. For each mutant,
control experiments conﬁrmed that the depletion of 5a was
dependent on the presence of both 3 and enzyme. This indicates
that the conversion of 5a was indeed the result of an enzyme-
catalysed Michael-type addition of 3 to 5a (rather than the
enzyme-catalysed addition of water to 5a).
The mutability landscape shows that the majority of mutations
does not have a signiﬁcant effect on this ‘Michaelase’ activity of
4-OT (Fig. 3b). This demonstrates the mutational robustness of
the enzyme for this promiscuous activity. The key functionally
important residue that can be identiﬁed from the mutability
landscape is Arg-39, which is in accordance with the proposed
mechanism of this Michael-type addition reaction, in which
Arg-39 serves as a catalytic acid29. The observation that the
activity is partially restored when Arg-39 is replaced by a
positively charged residue that could function also as an acid
(Lys or His) further strengthens this proposed mechanistic role of
Arg-39. Interestingly, the other active-site arginine (Arg-11)
appears to be less important for this promiscuous ‘Michaelase’
activity (Fig. 3b), whereas it was shown to be essential for the
phenylenolpyruvate tautomerase activity of 4-OT (Fig. 3a).
Residues around and in the b-hairpin element (Gly-51 to
Leu-56) also appear to be important for this Michael-type
addition activity of 4-OT. Especially mutations at the positions
of Phe-50 and the two glycine residues in the middle of the
b-hairpin seem to have a large functional effect.
Most notably, four mutations at position Ala-33 result in an
improved ‘Michaelase’ activity of 4-OT. When this residue was
replaced by negatively charged residues (Asp or Glu), or the
corresponding polar residues (Asn or Gln), the activity was
signiﬁcantly enhanced. Of these mutants, variant A33D had a
3.5-fold increase in speciﬁc activity, making it the most active
single 4-OT mutant for this Michael-type addition reaction.
In contrast, the phenylenolpyruvate tautomerase activity of
variant A33D was reduced B8-fold when compared with that
of wild-type 4-OT.
The preparative usefulness of the A33D mutant was compared
with that of wild-type 4-OT by transformations using 0.7mol%
biocatalyst and a 25-fold excess of 3 (50mM) over 5a (2mM).
Analysis of the progress curves of these reactions conﬁrmed
that mutant A33D is more efﬁcient in the addition of 3 to 5a
than wild-type enzyme (Fig. 4a), with the A33D-catalysed
reaction being completed within just 90min at room
temperature. The products were puriﬁed and characterized using
1H NMR spectroscopy, chiral phase high-performance liquid
chromatography (HPLC) and optical rotation measurements
(Supplementary Figs 2 and 3, and Supplementary Table 1). This
analysis revealed that in addition to enhanced activity, mutant
A33D also has improved enantioselectivity compared with
wild-type 4-OT (Table 1, compare entries 1 and 2), producing
the 3S enantiomer of 4-nitro-3-phenylbutanal (6a) with an
enantiomeric ratio (e.r.) of 99:1. The isolated product yield could
be improved by conducting the enzymatic reaction at pH 6.5
instead of pH 7.3 (Table 1, entries 4 and 5, and Supplementary
Figs 4–6), lowering the amount of byproducts formed, which
result from the inherent tendency of acetaldehyde to rapidly react
with itself, forming oligomers44. This makes the A33D mutant a
promising biocatalyst for application in the asymmetric synthesis
of enantiopure 3S-6a.
Figure 3 | Mutability landscapes of 4-OT for tautomerase and promiscuous ‘Michaelase’ activities. The horizontal axes of the data matrices depict
the wild-type sequence of 4-OT and the vertical axes depict the 20 possible amino acid residues. The wild-type amino acid residue at each position is
indicated by bold squares. Grey boxes represent mutants that were not produced above the detection limit (0.5mgml 1 in the CFE) and white boxes
represent mutants that were not present in the collection. The colour indicates the speciﬁc activity of each mutant relative to that of wild-type 4-OT
((Umutmg 1)/(Uwtmg 1)). All activities were determined using ultraviolet spectroscopy (details can be found in the Methods section) and enzyme
concentrations in CFE were individually determined for each 4-OT variant using quantitative densitometric analysis of SDS gels. Each screening plate
contained samples of wild-type 4-OT of which the average speciﬁc activity was used to calculate the relative speciﬁc activities of all 4-OT variants on
that same plate. (a) The mutability landscape of 4-OT for tautomerase activity using substrate 8 (n¼4). (b) The mutability landscape of 4-OT for the
Michael-type addition of 3 to 5a (n¼ 2). (c) The mutability landscape of 4-OT for the Michael-type addition of 4 to 5a (n¼ 2). (d) The secondary-structure
elements of 4-OT20.
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Synthetic usefulness of the A33D mutant enzyme. To further
demonstrate the synthetic usefulness of the A33D mutant
enzyme, we used this biocatalyst in the Michael-type addition of
acetaldehyde (3) to a series of aromatic and aliphatic nitrooleﬁn
acceptors (5b–5g; Table 2). Nitroalkene (2–5mM), acetaldehyde
(50–150mM) and A33D enzyme (0.5–5.3mol%) were incubated
in an appropriate solvent system, and reactions were followed by
ultraviolet spectroscopy (Supplementary Figs 9–14). After com-
plete conversion of the respective nitroalkene, standard workup
and puriﬁcation procedures were carried out, which yielded
g-nitroaldehydes 6b–6g as conﬁrmed by 1H NMR spectroscopy
(Supplementary Figs 15–20). Analysis of products 6b–6g by
HPLC or gas chromatography (GC) on a chiral stationary phase
(Supplementary Figs 21–26) revealed that the A33D-catalysed
Michael-type addition reactions are highly enantioselective, pro-
ducing these g-nitroaldehydes with excellent e.r. values between
95:5 and 499:1 (Table 2). These results clearly demonstrate the
potential of the A33D mutant enzyme for application in enan-
tioselective synthesis of various g-nitroaldehydes. The discovery
of the A33D mutant illustrates the opportunities for protein
improvement afforded by experimental protein mutability land-
scapes; this single mutant would probably not have been gener-
ated by using an error-prone PCR approach, because the codon
for Ala-33 in 4-OT (GCG) requires two point mutations to
produce an aspartate (GAT or GAC).
Mutability landscapes of 4-OT for the addition of 4 to 5a. To
gain further insight into which residues govern the activity and
enantioselectivity of 4-OT in Michael-type addition reactions, we
determined the effect of each mutation on the ability of 4-OT to
catalyse the addition of butanal (4) to trans-b-nitrostyrene (5a),
and to yield enantioenriched product 7. The addition of 4 to 5a
was chosen as a model reaction for determining the mutational
effect on stereoselectivity, because the diastereo- and
enantiopurity of product 7 can be determined directly by HPLC
on a chiral stationary phase (Supplementary Fig. 27 and
Supplementary Table 2), whereas the separation of the enantio-
mers of product 6a (from the enzymatic addition of 3 to 5a)
by chiral-phase HPLC requires derivatization29,30. To prevent
epimerization of product 7 and minimize the formation of side
products, reactions were performed at pH 5.5 instead of pH 7.3
(ref. 30). Under these conditions, however, slight protein
precipitation was observed with some mutants, precluding
accurate activity measurements.
Nevertheless, the mutability landscape clearly demonstrates
the mutational robustness of the C-terminal domain (Ala-57 to
0
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Figure 4 | Enzyme-catalysed transformations. (a) Progress curves of the Michael-type addition of acetaldehyde 3 (50mM) to trans-nitrostyrene 5a
(2mM, 18mg) catalysed (0.7mol%) by wild-type 4-OT or 4-OT mutants A33D or M45Y/F50A. The reactions were carried out in buffer (20mM
NaH2PO4/10% ethanol (v/v)) at pH 7.3. (b) Progress curves of the Michael-type addition of butanal 4 (50mM) to trans-nitrostyrene 5a (2mM, 18mg)
catalysed (0.7mol%) by wild-type 4-OT or 4-OT mutants R39E, H6M/A33E/F50V or M45Y/F50A. The reactions were carried out in buffer (20mM
NaH2PO4/10% ethanol (v/v)) at pH 5.5. These progress curves are derived from the preparative scale reactions listed in Table 1.
Table 1 | Preparative scale Michael-type addition reactions of aldehydes (3 or 4) to trans-nitrostyrene (5a) catalysed by
wild-type 4-OT or 4-OT mutants (0.7mol%).
Entry Substrates Catalyst Solvent pH Reaction time (h) Yield (%) d.r.* (syn:anti) e.r.w Abs.z conf. Product
1 3 and 5a WT 4-OT 7.3 6 36y — 93: 7 3S 6a
2 3 and 5a A33D 7.3 1.5 28y — 99: 1 3S 6a
3 3 and 5a M45Y/F50A 7.3 3 30y — 94: 6 3R 6a
4 3 and 5a WT 4-OT 6.5 1.8|| 94 — 95: 5 3S 6a
5 3 and 5a A33D 6.5 0.7|| 94 — 99: 1 3S 6a
6 3 and 5a M45Y/F50A 5.5 21 65 — 96: 4 3R 6a
7 4 and 5a WT 4-OT 5.5 23 67 91: 9 57: 43 2R3S 7
8 4 and 5a H6M/A33E/F50V 5.5 1 76 97: 3 77: 23 2S3R 7
9 4 and 5a R39E 5.5 23 67 93: 7 95: 5 2R3S 7
10 4 and 5a M45Y/F50A 5.5 2.5 86 96: 4 96: 4 2S3R 7
HPLC, high-performance liquid chromatography; 4-OT, 4-oxalocrotonate tautomerase.
*The d.r. values were determined by 1H NMR spectroscopy (Supplementary Fig. 7).
wThe e.r. values were determined by HPLC on a chiral stationary phase (Supplementary Figs 3, 6 and 8).
zThe absolute conﬁguration of the major enantiomers was determined by comparison of chiral-phase HPLC data and optical rotation data with literature data (Supplementary Table 1).
yAt pH 7.3, the formation of undeﬁnable side products, resulting from the inherent tendency of acetaldehyde to form oligomers44, requires product puriﬁcation by ﬂash column chromatography, which
lowers the isolated yield of the desired product 6a.
||Catalyst loading (1.4mol%) was used.
The progress curves for these preparative scale reactions are given in Fig. 4 and Supplementary Fig. 4.
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Arg-62) of 4-OT for the Michael-type addition of 4 to 5a
(Fig. 3c). This robustness of the C-terminal domain has also been
observed for the other two activities analysed (Fig. 3a,b), which
may suggest a minor contribution of this domain to catalysis. The
overall mutational robustness of 4-OT for the Michael-type
addition of 4 to 5a, however, seems less when compared with the
Michael-type addition activity of 3 to 5a. This may be related to
the difference in the pH of the assay buffer (pH 5.5 versus pH 7.3).
Importantly, the mutability landscape (Fig. 3c) revealed four
residue positions at which mutations signiﬁcantly improved the
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HPLC, high-performance liquid chromatography; 4-OT, 4-oxalocrotonate tautomerase.
*Compared with nitroalkene. The amounts of applied A33D enzyme (0.5–5.3mol%) were adjusted such that conversions of 5a–5g were all completed within 2.5 h. For conversion of 5g into 6g, 5.3mol%
of enzyme was required to outcompete non-enzymatic water addition to 5g31.
wDetermined by HPLC or GC analysis on a chiral stationary phase.
#The reaction was performed at pH 6.5 instead of pH 5.5 (full details on the reaction conditions are given in the Methods section).
zThe absolute conﬁguration was determined by chiral-phase HPLC and comparison with literature data.
yThe absolute conﬁguration of the major enantiomer could be tentatively assigned based on analogy and the sign of optical rotation.
||The absolute conﬁguration of the major enantiomer was determined by chiral-phase GC and comparison with literature data.
zThe deviant conﬁguration of 6g is due to different prioritization of the substituents at the chiral centre relative to 6a–f.
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speciﬁc activity of 4-OT for the Michael-type addition of 4 to 5a.
The higher number of favourable mutations found for this
reaction, when compared with the Michael-type addition of 3 to
5a, could be the result of the additional ethyl group on the
aldehyde substrate, which could serve as an extra handle for the
enzyme to coordinate substrate binding. The ﬁrst position where
beneﬁcial single mutations (Val, Ile, Leu or Met) were found is
His-6. For this position, the best mutant enzyme was H6M, which
has an B3-fold increased speciﬁc activity compared with that of
wild-type 4-OT. The second position is Ala-33, which on
mutation to a Glu improved the speciﬁc activity B4-fold
compared with that of wild-type 4-OT (a Gln at this position
improved the activity slightly). Notably, the A33E mutation also
signiﬁcantly improved the activity of 4-OT for the Michael-type
addition of 3 to 5a (Fig. 3b). The third position is Met-45; at this
position, four single mutations improved the activity, including
mutations to Ile (2.1-fold), Tyr (2.3-fold), His (3.6-fold) and Thr
(2-fold). Finally, at position Phe-50, mutations to Leu and Val
improved the speciﬁc activity 2.5- and B5-fold, respectively,
compared with that of wild-type 4-OT. This makes the F50V
enzyme the most active single 4-OT mutant for the Michael-type
addition of 4 to 5a (Supplementary Fig. 28 and Supplementary
Table 3). These identiﬁed hotspots are good targets to further
enhance 4-OT’s promiscuous ‘Michaelase’ activity, as shown by
combinatorial mutagenesis, which yielded a triple mutant, H6M/
A33E/F50V, with strongly enhanced activity for the Michael-type
addition of 4 to 5a (Fig. 4b, Table 1 and also see Supplementary
Discussion for full details).
No signiﬁcant changes in the diastereoselectivity were
observed, as all active mutant enzymes such as wild-type 4-OT
produced the syn diastereomer of 7 in large excess (diaster-
eomeric ratio (d.r.) Z72:28). This observation is consistent with
the postulated topological rule that explains the syn-selectivity in
diastereoselective Michael-type additions of enamines to nitroalk-
enes45. Wild-type 4-OT has enantiopreference towards the 2R3S
enantiomer of the syn diastereoisomer, producing 7 with an e.r. of
57:43 (2R3S:2S3R) (Table 1, entry 7). The effect of each mutation
on the ability of 4-OT to produce enantioenriched product 7 is
shown in Fig. 5. The mutability landscape shows that many single
mutations have a signiﬁcant effect on 4-OT’s enantioselectivity.
The residue positions where single mutations led to the most
pronounced improvement in enantioselectivity are Ala-33, Arg-
39, Ala-57 and Arg-61. A comparison of the mutability
landscapes suggests that in contrast to the mutational
robustness of the C-terminal domain for the natural and
promiscuous activities of 4-OT, this domain appears to
contribute largely to the enantioselectivity of 4-OT in the
Michael-type addition of 4 to 5a.
The single mutants with the best enantioselectivity at each of
these residue positions (A33D, R39E, A57Y and R61M) were
puriﬁed and characterized for their ability to produce enantioen-
riched products in the Michael-type addition of 4 to 5a, as well as
3 to 5a (Supplementary Table 4). Fully consistent with the
mutability landscape shown in Fig. 5, the enzyme R39E has the
highest enantioselectivity for the Michael-type addition of 4 to 5a,
producing g-nitroaldehyde 7 with an e.r. of 94:6 (2R3S:2S3R).
Although mutant R39E also displayed signiﬁcantly improved
enantioselectivity in the Michael-type addition of 3 to 5a,
producing 3S-6a with an e.r. of 96:4 (Supplementary Table 4),
mutant A33D has the highest enantioselectivity in this reaction
(vide supra).
The preparative usefulness of the R39E mutant was compared
with that of wild-type 4-OT by transformations using 0.7mol%
biocatalyst and a 25-fold excess of 4 (50mM) over 5a (2mM).
Analysis of the progress curves of these reactions showed that
R39E exhibits similar activity compared with WT 4-OT (Fig. 4b).
However, in contrast to wild-type 4-OT, R39E afforded highly
enantioenriched product 7 with an e.r. of 95:5 (Table 1, compare
entries 7 and 9). This makes the R39E mutant a promising
biocatalyst for application in the asymmetric synthesis of
enantioenriched 2R3S-7.
Interestingly, the mutability landscape (Fig. 5) further shows
that several single variants of 4-OT have inverted enantioselec-
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Figure 5 | Mutability landscape of 4-OT for enantioselectivity in the Michael-type addition of 4 to 5a. (a) The horizontal axis of the data matrix
depicts the wild-type sequence of 4-OTand the vertical axis depicts the 20 possible amino acid residues. The wild-type amino acid residue at each position
is indicated by bold squares and white boxes represent mutants that are not present in the collection. The colour indicates the e.r. (2R3S:2S3R) of the major
syn diastereoisomer of 7 as produced by the 4-OT variants. The e.r. values were determined by HPLC on a chiral stationary phase. Grey boxes represent
mutants that did not produce sufﬁcient amounts of 7 to give an adequate ultraviolet signal during HPLC analysis. As expected, these grey boxes
mainly coincide with the grey and dark blue boxes in Fig. 3c, which indicate mutants that either did not express or lack signiﬁcant ‘Michaelase’ activity.
(b) The secondary-structure elements of 4-OT20.
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2R3S enantiomer. Mutations at positions His-6, Arg-11, Met-45,
Phe-50 and Gly-54 had the most pronounced effect on inversion
of enantioselectivity. Three of these positions (His-6, Met-45 and
Phe-50) overlap with the positions at which single mutations were
identiﬁed, which improve 4-OT’s ‘Michaelase’ activity for
addition of 4 to 5a (Fig. 3c). The best mutant at each of these
positions (H6I, R11I, M45H, F50A and G54E) was puriﬁed and
characterized for its ability to produce enantioenriched products
in the Michael-type addition of both 3 to 5a and 4 to 5a. At
position Met-45, the second-best mutant was chosen for analysis,
because the best mutant at this position (M45Y) could not be
puriﬁed to homogeneity due to insufﬁcient expression (consistent
with the mutability landscape shown in Fig. 2a). Strikingly, all ﬁve
mutants did not only have inverted enantioselectivity for the






















































6a 0.7 o.n.# R‡
2 5b p-Cl-C6H4 6b R‡
3 5c p-F-C6H4 6c R‡
4 5d p-HO-C6H4 6d 0.5 o.n.# R§
5 5e 3-HO-4-MeO-C6H3 6e R
‡
6 5f 3-c-PentO-4-MeO-C6H3 6f R
‡
7 5g isobutyl 6g 
65 96:4
2.8 90 60 62:38
1.5 180 47 86:14
48 82:18
1.8 100 73 97:3
3.7 90 70 68:32
5.3 70 60 90:10 S||,¶
HPLC, high-performance liquid chromatography; 4-OT, 4-oxalocrotonate tautomerase; o.n., overnight.
*Compared with nitroalkene. The amounts of applied M45Y/F50A enzyme are identical to those of applied A33D enzyme (Table 2), enabling a direct comparison of catalytic performance. All reactions
were performed at pH 5.5 (full details on the reaction conditions are given in the Methods section).
wDetermined by HPLC or GC analysis on a chiral stationary phase.
#Entry 1, B21 h; entry 4, B16 h.
zThe absolute conﬁguration was determined by chiral-phase HPLC and comparison with literature data.
yThe absolute conﬁguration of the major enantiomer could be tentatively assigned based on analogy and the sign of optical rotation.
||The absolute conﬁguration of the major enantiomer was determined by chiral-phase GC and comparison with literature data.
zThe deviant conﬁguration of 6g is due to different prioritization of the substituents at the chiral centre relative to 6a–f.
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Michael-type addition of 4 to 5a but also for the Michael-type
addition of 3 to 5a (Supplementary Table 5). Of these mutants,
the enzyme F50A has the highest enantioselectivity producing
both 3R-6a and 2S3R-7 with an e.r. of 93:7, demonstrating its
suitability for the preparation of the opposite enantiomers (as
compared with those produced in the same reactions catalysed by
A33D, R39E or wild-type 4-OT) of g-nitroaldehydes 6a and 7.
Engineering 4-OT variants with inverted enantioselectivity. To
further improve the selectivity of 4-OT towards the 2S3R enan-
tiomer of 7, we generated double and triple mutants based on all
possible combinations of the best single 4-OT mutants (that is,
H6I, M45H or M45Y, and F50A). Using analytical scale assays,
these double- and triple-mutant enzymes were evaluated for their
enantioselectivity in the Michael-type addition of 4 to 5a, yielding
7. Three (H6I/M45H, H6I/M45Y and H6I/M45H/F50A) of the
seven constructed mutant enzymes displayed either low or no
detectable ‘Michaelase’ activity. Gratifyingly, the other four
mutants (H6I/F50A, M45Y/F50A, M45H/F50A and H6I/M45Y/
F50A) displayed respectable activity and produced 7 with an e.r.
496:4 (2S3R:2R3S) (Supplementary Table 6). This product
enantiopurity is higher than that obtained with the best single
mutant (F50A), indicating an additive effect of the mutations.
The preparative usefulness of the mutant with the best activity
and enantioselectivity, M45Y/F50A, was analysed by transforma-
tions using 0.7mol% biocatalyst and a 25-fold excess of aldehyde
(3 or 4) over 5a. The progress curves of these reactions
demonstrate that this mutant, in addition to inverted enantios-
electivity, also has signiﬁcantly enhanced ‘Michaelase’ activity for
the addition of 3 to 5a (Fig. 4a), as well as 4 to 5a (Fig. 4b) when
compared with wild-type 4-OT. The M45Y/F50A-catalysed
Michael-type addition of 4 to 5a gave 2S3R-7 in excellent yield
(86%) and with high enantiopurity (96:4) (Table 1, entry 10).
Interestingly, the M45Y/F50A mutant also displayed high
enantioselectivity in the Michael-type addition of 3 to 5a, yielding
3R-6a with an e.r. of 94:6 and a yield of 30% (Table 1, entry 3).
The product yield could be improved to 65% by conducting the
enzymatic reaction at pH 5.5 (Table 1, entry 6), which lowers the
amount of side-products formed.
Synthetic usefulness of the M45Y/F50A mutant enzyme. To
further demonstrate the usefulness of the M45Y/F50A mutant for
synthesis of the opposite enantiomers of g-nitroaldehydes 6b–6g,
as compared with those afforded by mutant A33D (Table 2), we
also used this engineered enzyme in the Michael-type addition of
acetaldehyde (3) to the nitrooleﬁn acceptors 5b–5g (Table 3).
After complete conversion of the respective nitroalkene
(Supplementary Figs 9–14), standard workup and puriﬁcation
procedures were carried out, affording g-nitroaldehydes 6b–6g
(Supplementary Figs 15–20). Analysis of these enzymatic pro-
ducts by chiral-phase HPLC or GC (Supplementary Figs 21–26)
revealed that the M45Y/F50A-catalysed Michael-type addition
reactions indeed yield the opposite enantiomers of g-nitroalde-
hydes 6b–6g with e.r. values between 62:38 and 97:3 (Table 3).
These results clearly demonstrate the potential of the M45Y/F50A
enzyme for application in the synthesis of enantioenriched
3R-6b-6f and 3S-6g, which are valuable precursors for pharma-
ceutically active GABA analogues, and further illustrate the
exciting opportunities for enzyme engineering afforded by
experimental protein mutability landscapes for enantioselectivity.
Structural consequences of the M45Y and F50A mutations. To
obtain insight into the structural consequences of the M45Y and
F50A mutations, we determined crystal structures of mutant
M45Y/F50A in an unliganded state and in complex with substrate
trans-b-nitrostyrene (5a) at 2.7 and 2.3 Å resolution, respectively
(Supplementary Table 7 and Supplementary Fig. 29). The overall
structure of the M45Y/F50A mutant did not reveal signiﬁcant
changes in backbone conformation compared with wild-type 4-
OT. Hexameric Ca backbones of mutant and wild-type 4-OT
superimpose with an average root-mean-square deviation of
0.32 Å (Supplementary Fig. 30). However, the M45Y and F50A
mutations did have a pronounced effect on the active-site geo-
metry near Pro-1 (Fig. 6a and Supplementary Fig. 31a,b). In the
wild-type 4-OT structure, the side chains of Met-45 and Phe-50
point towards Pro-1, restricting access to a small hydrophobic
pocket at the back of the active site. In the structure of mutant
M45Y/F50A, the side chain of Tyr-45 is rotated away from Pro-1
towards the back of the active site, where it forms a hydrogen
bond with His-6 (Supplementary Fig. 31c). Combined with the
replacement of the bulky Phe-50 with an alanine, the M45Y
mutation results in a signiﬁcant opening and enlargement of the
hydrophobic pocket near Pro-1 (Fig. 6a and Supplementary
Fig. 31a,b). This enlarged pocket in the M45Y/F50A mutant is
able to accommodate the phenyl group of 5a, as revealed in the
crystal structure of mutant M45Y/F50A complexed with this
substrate (Fig. 6b). The phenyl group of 5a makes van der Waals
contacts with residues Pro-1, His-6, Ile-7, Leu-8 and Ile-41 in the
hydrophobic pocket, whereas the nitro group is in van der Waals
























Figure 6 | Structural characteristics of the M45Y/F50A mutant. (a) Superposition of the residues lining the hydrophobic Pro-1 pocket in wild-type 4-OT
(orange) and the M45Y/F50A mutant (green). (b) Surface and stick representation of the Pro-1 pocket in the M45Y/F50A mutant, depicting the bound
trans-b-nitrostyrene (orange) as observed in the crystal structure. The grey mesh shows the 2Fo Fc electron density contoured at 1.0s. Residues from the
neighbouring chains are shown in different colours and labelled with apostrophes. The hydrogen-bonding interactions (distances in Å) are shown as black
dashed lines.
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group of Arg-39. The central ethylene group of 5a is only B3Å
away from the amino group of Pro-1. The observed binding mode
of 5a in the structure of mutant M45Y/F50A is not possible in the
wild-type 4-OT structure, due to steric hindrance by the Phe-50
and Met-45 residues.
In conclusion, our results reveal that the two mutations (M45Y
and F50A) unexpectedly created a new substrate-binding pocket.
This active-site remodelling is most probably responsible for the
observed differences in activity and enantioselectivity between
mutant and wild-type 4-OT. However, these ﬁndings per se do
not explain the enantiopreference of mutant M45Y/F50A. The
electron density for bound 5a does not indicate a preference of
this substrate to bind with an orientation relative to Pro-1 that is
consistent with the formation of the (R)-product; the other
orientation differing by a rotation of B180 around the
longitudinal axis of the substrate molecule, and consistent with
formation of the (S)-product, ﬁts equally well (Supplementary
Fig. 31d). In addition to highlighting that active-site remodelling
may lead to inverted enantioselectivity, our crystallographic
results provide an important guide for future engineering
experiments.
Discussion
In summary, we provide evidence that a catalytically promiscuous
tautomerase is a good starting point to develop novel enantio-
complementary biocatalysts for unnatural Michael-type additions
of acetaldehyde (or butanal) to various nitroalkenes. These
enzyme-catalysed reactions provide ready access to both
enantiomers of g-nitroaldehydes, given that the product yields
may be further improved by optimizing the reaction conditions
and puriﬁcation protocols. This new biocatalytic procedure
provides an attractive complement to existing organocatalytic
methodologies. Chiral g-nitroaldehydes are valuable building
blocks for GABA derivatives and their rapid synthesis should
facilitate the development of new pharmaceuticals.
The applied systematic mutagenesis strategy allows the
important discrimination between beneﬁcial mutations and those
that are neutral or detrimental, providing detailed insight into
sequence–function relationships. The results provide support for
the notion that the generation of large-scale mutational data,
revealing the functional consequences of a great number of
protein variants, may have important implications for under-
standing and engineering proteins46–48. Interestingly, the
mutability landscapes of 4-OT demonstrate that in contrast to
the mutational robustness of the C-terminal domain for 4-OT’s
different activities, this domain appears to contribute largely to
the enantioselectivity of the enzyme in the Michael-type addition
reaction. Hence, this domain may represent a good target for
future mutagenesis experiments, with the aim to optimize the
enantioselectivity of 4-OT in Michael-type additions using
different combinations of aldehyde and nitroalkene. We also
aim to exploit the large amount of mutational data generated
within this study, which can be used as a unique training set, and
machine learning algorithms to generate mutation prediction
models for 4-OT as well as closely related tautomerase
superfamily members.
Methods
Mutant collection preparation. To create mutability landscapes of 4-OT, a
deﬁned collection of 1,040 single mutant 4-OT genes was purchased from DNA2.0
(Menlo Park, CA). This collection covered at least 15 of the 19 possible variants on
each amino acid residue position ranging from Ile-2 to the C-terminal Arg-62. In
total, 90% of all possible single 4-OT mutants is present in this collection. Each
mutant gene was individually cloned in a pJexpress 414 vector, sequenced and
transformed into E. coli DH10B by DNA2.0. Each DH10B culture, which carried a
mutated 4-OT gene in a pJexpress 414 vector, was separately grown in liquid
lysogeny broth (LB) containing 100 mgml 1 ampicillin (amp). All plasmids, each
containing a single mutant 4-OT gene, were isolated from these cultures using the
NucleoSpin 96 Plasmid Core Kit (Bioke´, Leiden, NL). An aliquot of each isolated
plasmid was transformed individually into chemically competent E. coli
BL21 (DE3). The transformants were selected at 37 C in liquid LB containing
100 mgml 1 amp. Each E. coli BL21 (DE3) transformant harbouring a pJexpress
414 vector with a unique 4-OT gene was stored at  80 C until further use.
CFE production and enzyme concentration assessment. The expression levels,
activities and enantioselectivities of all members of the 4-OT mutant collection
were determined using cell-free extracts (CFEs) of cultures each expressing a
different 4-OT mutant. To inoculate these cultures, aliquots of the  80 C stock of
the transformed E. coli BL21 (DE3) cells were placed into wells of a 2.2-ml 96-deep-
well plate (Greiner Bio-one, 96-well Masterblock). Each mutant was placed into
two wells as a duplicate. Each well contained 1.25ml LB, supplemented with
100 mgml 1 amp and 100 mM isopropyl-b-D-1-thiogalactopyranoside as an
inducer. The deep-well plates with inoculated LB medium were sealed with sterile,
gas-permeable seals (Greiner Bio-one, BREATHseal) and incubated overnight at
37 C with shaking at 250 r.p.m. After the incubation, the cultures were pelleted at
3,500 r.p.m. for 30min at 4 C. The pellets of the duplicates were pooled and lysed
with 375 ml BugBuster (Novagen), which was supplemented with 25Uml 1
benzonase nuclease. The cell lysates were incubated with vigorous shaking at room
temperature for 20min. The cell lysate was cleared by centrifugation at 4,000 r.p.m.
for 20min at 4 C, after which the CFE was obtained as the supernatant. To assess
the 4-OT concentration in each CFE, 2 ml of each CFE was mixed with 18ml of
protein sample buffer (containing 9% (w/v) SDS, 40% (v/v) glycerol, 20% (v/v)
b-mercaptoethanol, 0.1% (w/v) bromophenol blue and 250mM Tris pH 6.8). Of
the ﬁnal mixture, which contained CFE and protein sample buffer, 10 ml was loaded
on a 26-well pre-cast 10% polyacrylamide gel (NuPAGE Novex 10% Bis-Tris). Four
samples with standard amounts of 0.5, 1, 2.5 and 5 mg of homogenous wild-type
4-OT were loaded on the gel besides the CFE samples and served as calibration
samples for the quantiﬁcation of the 4-OT mutant protein in the CFE. The
puriﬁcation method of wild-type 4-OT is described elsewhere28. The concentration
of the puriﬁed wild-type 4-OT was determined by the Waddell method49. After
electrophoresis (at 150V for 1 h), the gels were stained using the Coomassie-based
stain InstantBlue (Expedeon Ltd). A digital image of the gel was recorded using the
Chemi Genius2 Bio Imaging System (Syngene, Cambridge, UK). A typical picture
of an SDS-gel, which was used in this densitometric concentration assessment, is
present in Supplementary Fig. 1. The concentrations of the 4-OT mutants in the
CFE were quantiﬁed based on the size and intensity of the 4-OT bands on the
digital image of the gel, relative to the 4-OT bands used for calibration. The
calibration samples were present on each gel and were only used to quantify 4-OT
concentrations of the samples that were loaded on that same gel. The size and
intensity of the protein bands were quantiﬁed by using the software GeneTools
(version 4.02, Syngene) and were used to make a calibration curve. The average R2
value of the 122 calibration curves, used to determine all expression levels, was
0.97. This indicates the accuracy of this quantiﬁcation method. This concentration
assessment preceded each activity screening of each CFE sample. The CFE was
stored at room temperature (o5 h) until further use. The mutability landscape of
4-OT for the expression of soluble protein was generated using the data obtained
from these concentration assessments. The mutability landscape was generated
using Microsoft Excel 2010.
Mutability landscapes of 4-OT for activity. All enzymatic activities of the 4-OT
mutants were determined by ultraviolet spectroscopy. The ultraviolet-spectroscopic
measurements were done in 96-well microtitre plates (MTPs) (UV-star mclear,
Greiner Bio-one). The volume of the reaction mixtures in all wells was 100 ml and
the temperature in the ultraviolet-plate reader was set to 25 C for all analyses.
Mutability landscape of 4-OT for tautomerase activity using
phenylenolpyruvate (8). The tautomerase activity of the 4-OT mutants was
assessed by determining their ability to ketonize phenylenolpyruvate (8). The ﬁnal
reaction mixtures consisted of the following: CFE (0.2% v/v), phenylenolpyruvate
(400 mM (two times Km of wild-type 4-OT)39) and ethanol (10% v/v) in 10mM
NaH2PO4 buffer (pH 7.3). First, the CFE and buffer were added to each well of
the MTP using a Packard Multiprobe II HT EX 8 tip robotic liquid handling
system. The assay was initiated by the addition of 10 ml stock solution of
phenylenolpyruvate (4.0mM in ethanol) to each well of the MTP, which already
contained the appropriate CFE and buffer mixture using the integrated reagent
injector on the SPECTROstar Omega plate reader (BMG LABTECH, Isogen Life
Science, de Meern, NL). After adding the substrate to one well, the plate was brieﬂy
shaken (2 s at 500 r.p.m.) before that well was analysed for 40 s at 283 nm with a
0.26-s data interval, following the depletion of 8. After ﬁnishing the measurement
in one well of the MTP, the substrate was added to the next well to initiate the assay
in that well. These reaction conditions enabled accurate rate determination in the
range of ﬁvefold decreased to ﬁvefold increased activity compared with wild-type
4-OT. This activity assay was done in quadruplicate.
Mutability landscape of 4-OT for the Michael-type addition of acetaldehyde (3)
to trans-b-nitrostyrene (5a). The reaction mixtures used to monitor the
4-OT-catalysed Michael-type addition of 3 to 5a consisted of the following: CFE
(40% v/v), substrate 5a (500 mM (two times Km of wild-type 4-OT)29), substrate
3 (50mM) and ethanol (5% v/v) in 10mM NaH2PO4 buffer (pH 7.3). First, the
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appropriate amounts of CFE and buffer were added to each well of the MTP using
a Packard Multiprobe II HT EX 8 tip robotic liquid handling system. The assay was
initiated by adding 10 ml of a stock solution of 3 (500mM in 10mM NaH2PO4
buffer (pH 7.3)) and 5 ml of a stock solution of 5a (10mM in ethanol) to each well
of the screening plate, which already contained the appropriate CFE and buffer
mixture. To ensure proper mixing of the reagents, the plate was shaken (30 s at
500 r.p.m.) before the reaction rates were recorded by monitoring the depletion of
5a at 320 nm (lmax 5a¼ 320 nm) for 40min with a 60-s data interval. To observe
possible precipitation or other atypical changes in the reaction mixture, the
ultraviolet spectrum (220–500 nm) of each well was recorded before and after the
reaction. The activity assay was done in duplicate. Separate control experiments in
which the depletion rate of 5a was assessed in the presence of each 4-OT mutant,
but in the absence of aldehyde, indicated that none of the 4-OTs in the mutant
collection could catalyse the conversion of 5a at a signiﬁcant rate in the
absence of 3.
Mutability landscape of 4-OT for the Michael-type addition of butanal (4) to 5a.
The reaction mixture used to monitor the 4-OT-catalysed Michael-type addition of
4 to 5a consisted of the following: CFE (20% v/v), substrate 4 (32.5mM), substrate
5a (650 mM) and ethanol (5% v/v) in 50mM NaH2PO4 buffer (pH 5.5). First, the
appropriate amounts of CFE and buffer were added to each well of the MTP using
a Packard Multiprobe II HT EX 8 tip robotic liquid handling system. The assay was
initiated by adding 32.5 ml of a stock solution of 4 (100mM in 50mM NaH2PO4
(pH 5.5)) and 5 ml of a stock solution of 5a (13mM in ethanol) to each well of the
MTP, which already contained the appropriate CFE and buffer mixture. To
minimize evaporation of solvent and aldehyde 4, the MTPs were sealed with
ultraviolet transparent plate seals (VIEWseal, Greiner Bio-one). To ensure proper
mixing of the reagents, the plate was shaken (30 s at 500 r.p.m.) before the reaction
rates were recorded by monitoring the depletion of 5a at 320 nm for 80min with a
60-s data interval. To observe possible precipitation or other atypical changes in the
reaction mixture, the ultraviolet spectrum (220–500 nm) of each well was recorded
before and after the reaction. The buffer pH of 5.5 was used to prevent
epimerization of the product (7). The activity assay was done in duplicate.
Data analysis. The duplicates of the substrate depletion curves obtained in the
activity assays were combined and an average substrate depletion curve was
plotted. The initial substrate depletion rates were determined from the slopes of the
linear section of these curves using MARS data analysis software (version 2.40
(BMG LABTECH, Isogen Life Science)). The background substrate depletion rates
were determined separately for each assay by assessing the average initial rate of
substrate depletion in reaction mixtures containing CFE of E. coli BL21 (DE3)
cultures carrying an empty pJexpress 414 vector (EV). This background substrate
depletion rate was subtracted from all other substrate depletion rates determined
for 4-OT variants on that same MTP. When the resulting enzyme activity (U) was
zero, the sample was marked accordingly. The earlier established enzyme
concentrations in the CFEs were used to calculate the speciﬁc activities (Umg 1)
of each mutant. When an enzyme concentration in the CFE was lower than 0.5 mg
ml 1 (that is, the detection limit), the sample was marked accordingly. An average
of the wild-type 4-OT-speciﬁc activities was calculated for each MTP and all the
other speciﬁc activities of the mutants on the same MTP were divided by this value
to yield the relative speciﬁc activities ((Umutmg 1)/(Uwtmg 1)) of all
mutants. The EV and wild-type 4-OT controls were exclusively used for
calculations of relative activities of mutants on that same MTP. The data were
graphically represented in the mutability landscapes for activity, which were
generated using Microsoft Excel 2010.
Mutability landscape of 4-OT for enantioselectivity. Reverse-phase HPLC
method development for chiral separation of stereoisomers of 7. Racemic 2-ethyl-
4-nitro-3-phenylbutanal (7) was prepared according to a literature procedure30.
This racemic compound was used to test the ability of a Chiralpak ID column
(150mm 4.6mm, Daicel) to separate the 2R3S-7 and 2S3R-7 enantiomers, with
the aim of establishing a rapid reverse-phase HPLC method that could be used to
generate the mutability landscape of 4-OT for enantioselectivity. All four
stereoisomers of 7 could be separated using this column with an isocratic mobile
phase (MeCN:H2O 31:69) at a ﬂow rate of 1.5mlmin 1 (Supplementary Fig. 27).
The chromatogram was recorded using a diode array detector (210 or 220 nm). The
absolute conﬁguration of the syn-enantiomers was determined by injecting 7 that
was enzymatically produced by wild-type 4-OT, which produces the 2R3S-7
enantiomer in excess30. The in-house HPLC apparatus consisted of the following
components: Shimadzu LC-10 AT pump, a Shimadzu SIL-20A auto injector and a
Shimadzu SPD-M10A VP diode array detector. The HPLC chromatographic data
were analysed using data processing software (LC Solutions) obtained from
Shimadzu.
Supplementary Fig. 27a demonstrates the chiral separation of racemic 7 using the
above-mentioned HPLC conditions. As wild-type 4-OT has been reported to
produce 7 with a d.r. of 89:11 (syn:anti) and an e.r. of 69:31 (2R3S:2S3R)30, the
absolute conﬁguration of the syn-enantiomers could be assigned based on the HPLC
chromatogram of enzymatically produced 7 (Supplementary Fig. 27b and
Supplementary Table 2). As the enantioselectivity of wild-type 4-OT is unknown for
the anti-enantiomers, their absolute conﬁguration cannot be assigned. Therefore, the
peaks corresponding to the enantiomers of the anti-diastereoisomer are labelled as
‘anti-1’ and ‘anti-2’ based on the order of elution (Supplementary Fig. 27).
Generating the mutability landscape of 4-OT for enantioselectivity. The same
reaction mixtures that were used to monitor the Michael-type addition of 4 to 5a
catalysed by the 4-OT variants were also used to evaluate the ability of each 4-OT
variant to produce enantioenriched 7. The duplicate reaction mixtures were pooled
and ﬁltered using 96-well ultraﬁltration plates (AcroPrep Advance 96 Filter Plate
3 K Omega, Pall Life Sciences). The samples were passed through the ﬁlters by
applying vacuum. The ﬁltrate, which was now free of debris and protein, was
analysed for enantioenriched 7 by reverse-phase chiral HPLC, based on the above-
mentioned protocol. All four stereoisomers of the product 7 were separated using a
Chiralpak ID column (150mm 4.6mm, Daicel) as shown in Supplementary
Fig. 27. To decrease the retention times, the ﬂow rate was increased to
1.8mlmin 1 for the HPLC analyses used to generate the mutability landscape of
4-OT for enantioselectivity. The injection volume of the samples (that is, the
ﬁltered reaction mixtures) was 20 ml. The e.r. values were calculated based on the
peak integrations, which were determined at 210 nm. This data was graphically
represented in the mutability landscape for enantioselectivity, which was generated
using Microsoft Excel 2010.
Analytical scale determination of the ability of puriﬁed 4-OT variants to
produce enantioenriched 7. To measure the ability of puriﬁed 4-OT enzymes to
produce enantioenriched 7, analytical scale experiments were conducted. The
reaction mixtures for this consisted of the following: 4 (32.5mM), 5a (0.65mM),
65 mM 4-OT (monomer concentration) and ethanol (5% v/v) in 20mM NaH2PO4
buffer (pH 5.5); the ﬁnal volume of this reaction mixture was 2ml. The reaction
was followed by monitoring the depletion of 5a with ultraviolet spectroscopy at
320 nm. Aliquots of 200ml were taken from this reaction mixture, cleared by
ultraﬁltration using Nanosep 3K omega centrifugal ﬁlters (Pall Life Sciences) and
analysed by chiral reverse-phase HPLC using a Chiralpak ID column as described
above. The obtained e.r. values are depicted in Supplementary Tables 4 and 5.
Assessment of the ability of puriﬁed 4-OT variants to produce enantioenriched
6a. The reaction conditions used to assess the ability of puriﬁed 4-OT variants to
produce enantioenriched 6a was based on a previously described method30.
The reaction mixture consisted of the following: 4-OT (14.7 mM (0.7mol%)),
3 (50mM), 5a (2.0mM), and ethanol (10% v/v) in 20mM NaH2PO4 buffer
(pH 5.5). The reaction volume was 20ml. Ultraviolet spectra (200–400 nm) were
recorded at 30-min intervals to monitor the depletion of 5a. The reaction was
completed when the absorbance at 320 nm (lmax 5a¼ 320 nm) vanished. The
enzyme was removed from the reaction mixture by ultraﬁltration (Vivaspin
centrifugal concentrator (molecular weight cut off (MWCO) 5,000Da)). The
ﬁltrate was collected and extracted with ethyl acetate (3 10ml) using a separatory
funnel. The organic phases were combined, dried with MgSO4 and evaporated in
vacuo, yielding a yellowish oil. The product was dissolved in CDCl3 and a 1H NMR
spectrum was taken to conﬁrm the formation of 6a. All 1H NMR spectra were
recorded on a Bruker DRX-500 (500MHz) spectrometer and were referenced to
residual CHCl3 (d¼ 7.26). After conﬁrming that product 6a was obtained, it was
converted to its corresponding ethylene glycol acetal according to a literature
procedure29. The e.r. of the ethylene glycol acetal of 6a was determined based on a
literature procedure using reverse-phase HPLC with a Chiralpak AD-RH column
(150mm 4.6mm, Daicel) and an isocratic mobile phase (MeCN:H2O 70/30) at
0.5mlmin 1 (ref. 30). The obtained e.r. values are depicted in Supplementary
Tables 4 and 5.
Combinatorial mutagenesis of ‘hotspots’. Construction and screening of the
focused library to further improve the Michael-type addition (4 to 5a) activity of
4-OT. The mutability landscape revealed four residue positions at which mutations
improved the activity of 4-OT for the Michael-type addition of 4 to 5a. To further
improve this activity, a 4-OT mutant library was constructed in which the most
favourable mutations at these four positions were combined. The degeneracy at the
positions His-6, Ala-33 and Phe-50 was limited to the following amino acid
residues: His-6: H, I, L, M and V; Ala-33: A, D, E and Q; and Phe-50: F, V, L and A.
Complete degeneracy was used at position Met-45 by using an NNK codon. The
number of possible variants in this library equaled 1,600. To construct this library,
an equimolar mixture of the genes coding for A33D-, A33E-, A33Q- and wild-type
4-OT in the pJexpress 414 plasmid was used as a template in the PCR. The forward
primers were an equimolar mixture of oligonucleotides carrying a mutagenic codon
at position 6 (entry 7–11; Supplementary Table 8) and the reverse primers were an
equimolar mixture of oligonucleotides carrying a mutagenic codon at position 50
and an NNK codon at position 45 (entries 3–6; Supplementary Table 8). In total,
35 PCR cycles were carried out with the following temperatures and times:
denaturation at 95 C (30 s), annealing at 60 C (60 s) and elongation at 72 C
(60 s). The PCR product was gel puriﬁed, digested with NdeI and BamHI, and
cloned into an empty pJexpress 414 plasmid, which was compatibly digested and
treated with alkaline phosphatase. After the ligation, the plasmid was transformed
into chemically competent E. coli DH5a. The transformants were selected at 37 C
on LB agar plates containing 100 mgml 1 amp. Plasmid DNA was extracted from
a few randomly selected transformants and the entire 4-OT gene was sequenced, to
ensure that the desired mutations were introduced. After establishing that the
library was of good quality, the library was collected by pooling B5,200 DH5a
colonies, an aliquot of which was used for plasmid DNA isolation. An aliquot of
this isolated plasmid mixture was used to transform chemically competent E. coli
BL21 (DE3) cells. Transformants were selected at 37 C on LB agar plates
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containing 100mgml 1 amp. Of these transformants, 1,600 were randomly chosen
and grown in 1.25ml liquid LB/amp medium. These cultures were used to produce
CFE according to the above-mentioned protocol. The 4-OT mutants in the CFE
were screened for their activities for the Michael-type addition of 3 to 5a and 4 to
5a. The same assay conditions as described above were used, but without assessing
the 4-OT expression levels. After screening the 1,600 members, 55 were selected for
their pronounced activity. These mutants were again assayed for their Michael-type
addition activities (3 to 5a and 4 to 5a) and tested in a control assay monitoring the
depletion of 5a in the absence of aldehyde. In addition, the expression level of each
of the mutant enzymes was assessed using the densitometric assay as described
above. The most active mutant enzymes were identiﬁed based on their speciﬁc
activities relative to wild-type 4-OT ((Umutmg 1)/(Uwtmg 1)) for the
Michael-type additions. The plasmid DNA of the corresponding transformants was
extracted and the entire 4-OT gene was sequenced to identify the mutations.
4-OT puriﬁcation method. All 4-OT enzymes were puriﬁed using a procedure
described elsewhere28. This procedure required adjustments for the puriﬁcation of
the 4-OT mutants H6M/A33E/F50V and H6L/A33E/F50V. In these cases, the
elution of enzyme from the DEAE-sepharose column was done using 0.1M
Na2SO4 (instead of 0.5M). The protein precipitation was conducted with 1.6M
(NH4)2SO4 in accordance with the protocol. However, after the precipitation step
the concentration of (NH4)2SO4 was reduced to 1.0M by adding the appropriate
amount of 10mM NaH2PO4 buffer (pH 7.3). The solution was loaded on a phenyl-
sepharose column (equilibrated with 1.0M (NH4)2SO4) and washed with 1.0M
(NH4)2SO4 (instead of 1.6M). These adjustments were required because of the
higher binding afﬁnity of H6M/A33E/F50V and H6L/A33E/F50V for the
phenyl-sepharose column material compared with wild-type 4-OT. Puriﬁed
H6M/A33E/F50V and H6L/A33E/F50V enzymes were obtained in the
ﬂow-through and wash fractions during this column chromatography step. The
subsequent desalting, concentrating and concentration assessment of the puriﬁed
enzyme was done according to a literature procedure28. All puriﬁed 4-OT variants
were analysed by electrospray ionization mass spectrometry to conﬁrm the correct
mass of the proteins.
Characterization of H6L/A33E/F50V and H6M/A33E/F50V. To conﬁrm the
improved ‘Michaelase’ activity of the engineered 4-OT variants H6L/A33E/F50V
and H6M/A33E/F50V, a progress curve analysis was done using these biocatalysts
in the Michael-type addition of 4 to 5a (Supplementary Fig. 28). The reaction
mixture for this analysis consisted of the following: 4 (100mM), 5a (2mM), 4-OT
(0.7mol% relative to 5a, based on monomer concentration) and ethanol (5% v/v)
in 20mM NaH2PO4 (pH 5.5); the ﬁnal volume of this reaction mixture was 20ml.
Samples were taken from the reaction mixture and analysed by ultraviolet
spectroscopy (320 nm) at timely intervals, to monitor the depletion of 5a. After the
reaction was completed, product 7 was extracted with ethyl acetate (3 25ml). The
combined organic layers were dried using anhydrous MgSO4 and concentrated
in vacuo to yield 7. The product was analysed by chiral HPLC to establish the e.r.
values (Supplementary Table 3).
Construction and testing of double and triple 4-OT mutants for improved
enantioselectivity towards 2S3R-7. Double and triple mutants at positions His-6,
Met-45 and Phe-50 were constructed by PCR using the appropriate combinations
of template and primers. The gene coding for either M45Y, M45H or wild-type
4-OT in the pJexpress 414 vector was used as a template in the PCR in combination
with either reverse primer ‘Rev. WT 4-OT’ or ‘Rev. F50A’ and forward primer
‘Fwd. WT4-OT’ or ‘Fwd. H6I’ (Supplementary Table 8, entries: 1, 2, 7 and 8). The
PCR product was gel puriﬁed, digested with NdeI and BamHI, and cloned into an
empty pJexpress 414 plasmid, which was compatibly digested and treated with
alkaline phosphatase. After the ligation, the plasmid was transformed into
chemically competent E. coli DH5a cells. The transformants were selected at 37 C
on LB agar plates containing 100 mgml 1 amp. Plasmid DNA was extracted from
randomly picked transformants and the entire 4-OT gene was sequenced, to ensure
that the desired mutations were introduced. An aliquot of this plasmid solution was
used to transform chemically competent E. coli BL21 (DE3) cells. CFEs prepared
from cultures of these cells, expressing the 4-OT mutant proteins, were used to
determine the ability of these 4-OT mutants to produce enantioenriched 7 in the
Michael-type addition of 4 to 5a according to the earlier described protocol (see
above). The e.r. values of 7 produced by these mutants are listed in Supplementary
Table 6, depicting only those mutants that were active.
Semi-preparative scale synthesis experiments. Semi-preparative scale
synthesis of 6a. To demonstrate the synthetic usefulness of the 4-OT mutants
A33D and M45Y/F50A for the production of enantioenriched 6a, relative to
wild-type 4-OT, semi-preparative scale synthesis experiments were conducted
using these three enzymes. For this, an amount of enzyme (6 or 12mg) was added
to a 100-ml round-bottom ﬂask, after which 20mM NaH2PO4 buffer (pH 7.3, 6.5
or 5.5) was added, adjusting the ﬁnal volume to 54ml. The reaction was initiated by
the addition of 3 (170 ml) and 6ml of a stock solution of 5a (20mM in ethanol).
The ﬁnal concentrations were as follows: 5a (2mM), 3 (50mM), 4-OT (14.7 or
29.4 mM, based on monomer concentration) and 10% ethanol (v/v) in 20mM
NaH2PO4 buffer. Samples were taken from the round-bottom ﬂask at timely
intervals for ultraviolet spectrophotometric analysis, to monitor the reaction
progress by following the depletion of 5a (Fig. 4a and Supplementary Fig. 4).
After each measurement, the sample was recombined with the original reaction
mixture in the round-bottom ﬂask. When the depletion of 5a was complete, the
product (6a) was extracted with ethyl acetate (3 40ml) using a separatory funnel.
The organic phases were combined, dried with MgSO4 and evaporated in vacuo,
yielding a yellowish oil. The crude oil obtained after a reaction at pH 7.3 was
puriﬁed using ﬂash column chromatography (silica gel, ethyl acetate: n-Heptane
1:4 (v/v), 3mlmin 1 ﬂow); the fractions containing 6a were identiﬁed using
thin-layer chromatography (ethyl acetate: n-Heptane 1:2 (v/v), visualization:
KMnO4) and combined. The product was concentrated in vacuo, redissolved in
CDCl3 and a 1H NMR spectrum was recorded (Supplementary Fig. 2) on a Bruker
DRX-500 (500MHz) spectrometer; all spectra were referenced to residual CHCl3
(d¼ 7.26). The crude oil obtained after the reactions at pH 5.5 and pH 6.5 did not
require ﬂash chromatography, as the 1H NMR spectra (Supplementary Figs 2b and
5) indicated that 6a was obtained in high purity. After conﬁrming by 1H NMR
analysis that product 6a was obtained, the yields were determined (wild-type 4-OT:
8.2mg, 4.2 10 2mmol, 36%; M45Y/F50A: 6.9mg, 3.6 10 2mmol,
30%; M45Y/F50A (pH 5.5): 15.2mg, 7.9 10 2mmol, 65%; A33D: 6.5mg,
3.4 10 2mmol, 28%; wild-type 4-OT (pH 6.5): 22mg, 1.1 10 1mmol, 94%;
and A33D (pH 6.5): 22mg, 1.1 10 1mmol, 94%). Aliquots of 6a were converted
to their corresponding ethylene glycol acetals according to a literature procedure29.
The e.r. of the derivatized 6a was determined using reverse-phase HPLC with a
Chiralpak AD-RH column (150mm 4.6mm, Daicel) (see Supplementary Figs 3
and 6 for the chromatograms).
Semi-preparative scale synthesis of 7. To demonstrate the synthetic usefulness
of the 4-OT mutants H6M/A33E/F50V, R39E and M45Y/F50A for the production
of enantioenriched 7, relative to wild-type 4-OT, semi-preparative scale synthesis
experiments were conducted using these four enzymes. For this, 6mg of enzyme
was added to a 100-ml round-bottom ﬂask, after which 20mM NaH2PO4 buffer
(pH 5.5) was added, adjusting the ﬁnal volume to 54ml. The reaction was initiated
by the addition of 4 (540 ml) and 6ml of a stock solution of 5a (20mM in ethanol).
The ﬁnal concentrations were as follows: 5a (2mM), 4 (100mM), 4-OT (14.7 mM,
based on monomer concentration) and 10% ethanol (v/v) in 20mM NaH2PO4
buffer (pH 5.5). Samples were taken from the round-bottom ﬂask at timely
intervals for ultraviolet spectrophotometric analysis, to monitor the reaction
progress by following the depletion of 5a (Fig. 4b). After each measurement, the
sample was recombined with the original reaction mixture in the round-bottom
ﬂask. When the depletion of 5a was complete, the product (7) was extracted with
ethyl acetate (3 40ml) using a separatory funnel. The organic phases were
combined, dried with MgSO4 and evaporated in vacuo, yielding a yellowish oil. The
crude oil was dissolved in CDCl3 and a 1H NMR spectrum was recorded
(Supplementary Fig. 7) using a Bruker DRX-500 (500MHz) spectrometer (all
spectra were referenced to residual CHCl3 (d¼ 7.26)). After conﬁrming that
product 7 was obtained, the yields were determined and corrected for the presence
of small amounts of 2-nitro-1-phenylethanol (10), which is the product of the non-
enzymatic water addition to 5a (see Supplementary Fig. 7). The corrected yields
were as follows: wild-type: 17.7mg, 8.0 10 2mmol, 67%; H6M/A33E/F50V:
20.2mg, 9.1 10 2mmol, 76%; R39E: 17.6mg, 8.0 10 2mmol, 66%; and
M45Y/F50A: 22.7mg, 10.2 10 2mmol, 86%. The e.r. was determined using
reverse-phase HPLC with the Chiralpak ID column (150mm 4.6mm, Daicel)
(see Supplementary Fig. 8 for the chromatograms).
Optical rotation analysis of 6a and 7. The optical rotations of enzymatically
produced 6a and 7 were measured in CHCl3 on a SchmidtþHaensch polarimeter
(polartronic MH8) with a 10-cm cell (c is given in grams per 100ml). The data are
presented in Supplementary Table 1.
Semi-preparative scale synthesis of 6b–g using A33D and M45Y/F50A. To
investigate the synthetic usefulness of 4-OT A33D and 4-OT M45Y/F50A for the
enantioselective synthesis of g-nitroaldehydes 6b–g, semi-preparative scale
reactions were conducted using these engineered 4-OT variants. The reaction
conditions of these semi-preparative scale reactions and the e.r. determinations
were based on procedures described in earlier reports29,31. The general procedure
of these experiments was as follows: the appropriate amount of biocatalyst,
substrate 3 and co-solvent were diluted in buffer (20mM NaH2PO4, pH 5.5). The
reactions were initiated by the addition of the nitroalkene (5b–g) and the reaction
progress was monitored using ultraviolet spectrophotometric analysis. After the
ultraviolet signal of the nitroalkene vanished, the products (6b–g) were extracted
from the reaction mixtures and characterized by 1H NMR spectroscopy and chiral
HPLC or chiral GC, and the yields were determined. One adjustment on the earlier
reported reaction conditions was made in the buffer pH of the A33D-catalysed
reactions yielding compounds 6d and 6e. In these reactions, ethanol was used
as a co-solvent instead of dimethyl sulfoxide (DMSO) and the A33D enzyme
appeared to precipitate under these conditions. To reduce protein precipitation,
the buffer pH was increased to pH 6.5. More details on the reaction conditions
(Supplementary Table 9), work-up procedures and e.r. determinations are
listed below.
3-(4-Chlorophenyl)-4-nitrobutanal (6b). The 4-OT-catalysed Michael-type
addition of acetaldehyde (3) to trans-4-chloro-b-nitrostyrene (5b) using 4-OT
A33D or 4-OT M45Y/F50A was conducted under earlier reported optimized
reaction conditions31. The reaction mixtures consisted of the following: 4-OT
(2.8mol%, relative to 5b), 3 (65mM), 5b (1.3mM) and DMSO (45% v/v) in 20mM
NaH2PO4 buffer (pH 5.5); the ﬁnal reaction volume was 50ml (see Supplementary
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Table 9). After ultraviolet spectrophotometric analysis of the reaction mixtures
revealed full conversion of the nitroalkene (Supplementary Fig. 9), the reaction
mixtures were diluted with H2O till a ﬁnal DMSO concentration of 10% (v/v) was
reached. Next, compound 6b was extracted with ethyl acetate (3 60ml). The
combined organic layers were washed with H2O (3 60ml), to eliminate traces of
DMSO, and dried with brine (25ml) and anhydrous Na2SO4. The dried organic
layer was concentrated in vacuo to yield 3-(4-chlorophenyl)-4-nitrobutanal (6b)
(A33D: 12mg, 5.3 10 2mmol, 81% and M45Y/F50A: 9mg, 3.93 10 2mmol,
60%) as a colourless oil. The 1H NMR spectroscopic data of 6b (Supplementary
Fig. 15) are in agreement with previously published data1,31. Enantiomeric ratios
were determined by reverse-phase HPLC using a Chiralpak AD-RH column
(150mm 4.6mm, Daicel) (MeCN/water 32:68, 25 C) at 0.5mlmin 1.
Ultraviolet detection at 220 nm: tR: 3R-6b¼ 50.8min, 3S-6b¼ 54.6min led to
the following e.r. (3S:3R): racemic 6b¼ 50:50, 4-OT A33D 6b¼ 98:2 and 4-OT
M45Y/F50A 6b¼ 38:62 (Supplementary Fig. 21). The assignment of the absolute
conﬁguration was based on earlier reported chiral HPLC data31.
3-(4-Fluorophenyl)-4-nitrobutanal (6c). The 4-OT-catalysed Michael-type
addition of 3 to trans-4-ﬂuoro-b-nitrostyrene (5c) using 4-OT A33D or 4-OT
M45Y/F50A was conducted under earlier reported optimized reaction condi-
tions31. The reaction mixtures consisted of the following: 4-OT (1.5mol%, relative
to 5c), 3 (50mM), 5c (2.0mM) and DMSO (40% v/v) in 20mM NaH2PO4 buffer
(pH 5.5); the ﬁnal reaction volume was 60ml (see Supplementary Table 9). After
ultraviolet spectrophotometric analysis of the reaction mixtures revealed full
conversion of the nitroalkene (Supplementary Fig. 10), the reaction mixtures were
diluted with H2O till a ﬁnal DMSO concentration of 10% (v/v) was reached. Next,
compound 6c was extracted with ethyl acetate (3 60ml). The combined organic
layers were washed with H2O (3 60ml), to eliminate traces of DMSO, and dried
with brine (25ml) and anhydrous Na2SO4. The dried organic layer was
concentrated in vacuo to yield 3-(4-ﬂuorophenyl)-4-nitrobutanal (6c) (A33D:
16mg, 7.6 10 2mmol, 63% and M45Y/F50A: 12mg, 5.8 10 2mmol, 47%)
as a colourless oil. The 1H NMR spectroscopic data of 6c (Supplementary Fig. 16)
are in agreement with previously published data31,50. Enantiomeric ratios were
determined by reverse-phase HPLC using a Chiralpak AD-RH column
(150mm 4.6mm, Daicel) (MeCN/water 30:70, 25 C) at 0.5mlmin 1.
Ultraviolet detection at 220 nm: tR: 3R-6c¼ 37.4min, 3S-6c¼ 39.0min led to
the following e.r. (3S:3R): racemic 6c¼ 49:51, 4-OT A33D 6c¼ 99:1 and 4-OT
M45Y/F50A 6c¼ 14:86 (Supplementary Fig. 22). The assignment of the absolute
conﬁguration was based on earlier reported chiral HPLC data31.
3-(4-Hydroxyphenyl)-4-nitrobutanal (6d). The 4-OT-catalysed Michael-type
addition of 3 to trans-4-hydroxy-b-nitrostyrene (5d) using 4-OT A33D and 4-OT
M45Y/F50A was conducted based on earlier reported reaction conditions29. The
reaction mixtures consisted of the following: 4-OT (0.5mol%, relative to 5d),
3 (50mM), 5d (2.0mM) and ethanol (10% v/v) in 20mM NaH2PO4 buffer
(pH 6.5) for the A33D-catalysed reaction and in 20mM NaH2PO4 buffer (pH 5.5)
for the M45Y/F50A-catalysed reaction. The ﬁnal reaction volume was 60ml
(see Supplementary Table 9). After ultraviolet spectrophotometric analysis
of the reaction mixtures revealed almost complete nitroalkene conversion
(Supplementary Fig. 11), compound 6d was extracted with ethyl acetate
(3 40ml). The combined organic layers were dried with brine (25ml) and
anhydrous Na2SO4, and concentrated in vacuo to yield 3-(4-hydroxyphenyl)-4-
nitrobutanal (6d) (A33D: 11mg, 5.2 10 2mmol, 44% and M45Y/F50A: 13mg)
as a yellowish oil. 1H NMR spectroscopic analysis of the obtained product from the
4-OT M45Y/F50A-catalysed reaction revealed incomplete conversion (B92%) of
5d (Supplementary Fig. 17). The yield of the product obtained after the M45Y/
F50A-catalysed reaction was therefore corrected for this contamination of 6%
(w/w) 5d. The corrected yield of product 6d from the M45Y/F50A-catalysed
reaction was 12mg (5.8 10 2mmol, 48%). The 1H NMR spectroscopic data of
6d (Supplementary Fig. 17) are in agreement with previously published data29. The
aldehyde functionality of 6d was derivatized into a cyclic acetal to determine the
e.r. by reverse-phase HPLC using a Chiralpak AD-RH column (150mm 4.6mm,
Daicel) (MeCN/water 67:33, 25 C) at 0.5mlmin 1. Ultraviolet detection at
210 nm: tR: deriv.-3R-6d¼ 5.8min, deriv.-3S-6d¼ 8.0min led to the following e.r.
(3S:3R): racemic 6d¼ 51:49, 4-OT A33D 6d¼ 95:5 and 4-OT M45Y/F50A
6d¼ 18:82 (Supplementary Fig. 23). As a different stationary phase was used
compared with literature, the optical rotations of the enzymatically obtained
product 6d were recorded for assigning the absolute conﬁguration of the product.
The optical rotations were A33D 6d: ½a25D ¼  2:6 deg (c¼ 0.8, CHCl3) and YA
6d: ½a25D ¼ 11:0 deg (c¼ 1.3, CHCl3). The absolute conﬁguration of the major
enantiomers was tentatively assigned based on the sign of the optical rotation
compared with other g-nitroaldehydes and based on the assumption that A33D
and M45Y/F50A generate Michael-type addition products with a consistent
geometry at the chiral centre (see Tables 2 and 3)31.
3-(3-Hydroxy-4-methoxyphenyl)-4-nitrobutanal (6e). The 4-OT-catalysed
Michael-type addition of 3 to trans-4-methoxy-3-hydroxy-b-nitrostyrene (5e)
using 4-OT A33D or 4-OT M45Y/F50A was conducted under earlier reported
optimized reaction conditions31. The reaction mixtures consisted of the following:
4-OT (1.8mol%, relative to 5e), 3 (50mM), 5e (2.0mM) and ethanol (10% v/v)
in 20mM NaH2PO4 buffer (pH 6.5) for the A33D-catalysed reaction and in
20mM NaH2PO4 buffer (pH 5.5) for the M45Y/F50A-catalysed reaction. The ﬁnal
reaction volume was 60ml (see Supplementary Table 9). After ultraviolet
spectrophotometric analysis of the reaction mixtures revealed full conversion of the
nitroalkene (Supplementary Fig. 12), compound 6e was extracted from the reaction
mixture with ethyl acetate (3 25ml). The combined organic layers were dried
with brine (2 25ml) and anhydrous Na2SO4, and concentrated in vacuo
to yield 3-(3-hydroxy-4-methoxyphenyl)-4-nitrobutanal (6e) (A33D: 27mg,
11.2 10 2mmol, 94% and M45Y/F50A: 21mg, 8.8 10 2mmol, 73%) as a
colourless oil. The 1H NMR spectroscopic data of 6e (Supplementary Fig. 18) are in
agreement with previously published data31. The aldehyde functionality of 6e was
derivatized into a cyclic acetal to determine the e.r. by reverse-phase HPLC using a
Chiralpak AD-RH column (150mm 4.6mm, Daicel) (MeCN/water 33:67, 25 C)
at 0.8mlmin 1. Ultraviolet detection at 220 nm: tR: deriv.-3R-6e¼ 20.6min,
deriv.-3S-6e¼ 31.2min led to the following e.r. (3S:3R): racemic 6e¼ 49:51, 4-OT
A33D 6e¼ 99:1 and 4-OT M45Y/F50A 6e¼ 3:97 (Supplementary Fig. 24). The
assignment of the absolute conﬁguration was based on earlier reported chiral
HPLC data31.
3-(3-(Cyclopentyloxy)-4-methoxyphenyl)-4-nitrobutanal (6f). The 4-OT-
catalysed Michael-type addition of 3 to trans-4-methoxy-3-cyclopentyloxy-b-nitros-
tyrene (5f) using 4-OT A33D and 4-OT M45Y/F50A was conducted under earlier
reported optimized reaction conditions31. The reaction mixtures consisted of the
following: 4-OT (3.7mol%, relative to 5f), 3 (50mM), 5f (2.0mM) and DMSO (40%
v/v) in 20mM NaH2PO4 buffer (pH 5.5); the ﬁnal reaction volume was 60ml (see
Supplementary Table 9). After ultraviolet spectrophotometric analysis of the reaction
mixtures revealed full conversion of the nitroalkene (Supplementary Fig. 13), the
reaction mixtures were diluted with H2O till a ﬁnal DMSO concentration of 10% (v/v)
was reached. Next, compound 6f was extracted with ethyl acetate (3 60ml). The
combined organic layers were washed with H2O (3 60ml), to eliminate traces of
DMSO, and dried with brine (25ml) and anhydrous Na2SO4. The dried organic layer
was concentrated in vacuo, to yield 3-(3-(cyclopentyloxy)-4-methoxyphenyl)-4-
nitrobutanal (6f) (A33D: 24mg, 7.8 10 2mmol, 65% and M45Y/F50A: 26mg,
8.5 10 2mmol, 70%) as a colourless oil. The 1H NMR spectroscopic data of 6f
(Supplementary Fig. 19) are in agreement with previously published data4,31. The
aldehyde functionality of 6f was derivatized into a methyl ester (see ‘Derivatization of
6a, 6d, 6e and 6f for enantiomeric excess determination’), to determine the e.r. by
normal-phase HPLC using a Chiralpak IB column (150mm 4.6mm, Daicel) (n-
heptane/i-PrOH 95:5, 25 C) at 1mlmin 1. Ultraviolet detection at 220nm: tR:
deriv.-3R-6f¼ 12.0min, deriv.-3S-6f¼ 13.5min led to the following e.r. (3S:3R):
racemic 6f¼ 51:49, 4-OT A33D 6f499:1 and 4-OT M45Y/F50A 6f¼ 32:68
(Supplementary Fig. 25). The assignment of the absolute conﬁguration was based on
earlier reported chiral HPLC data31.
5-Methyl-3-(nitromethyl)hexanal (6g). The 4-OT-catalysed Michael-type
addition of 3 to (E)-4-methyl-1-nitropent-1-ene (5g) using 4-OT A33D or 4-OT
M45Y/F50A was conducted under optimized reaction conditions as earlier
reported31. The reaction mixtures consisted of the following: 4-OT (5.3mol%,
relative to 5g), 3 (150mM), 5g (3.0mM) and DMSO (40% v/v) in 20mM
NaH2PO4 (pH 5.5); the ﬁnal reaction volume was 12.8ml (see Supplementary
Table 9). After ultraviolet spectrophotometric analysis of the reaction mixtures
revealed full conversion of the nitroalkene (Supplementary Fig. 14) (A33D: 50min
and M45Y/F50A: 70min), compound 6g was extracted from the reaction mixture
with toluene (3 10ml) and the combined organic layers were washed with dH2O
(3 5ml) to eliminate traces of DMSO. The organic layer was dried with brine
(5ml) and anhydrous Na2SO4, and concentrated in vacuo to yield 5-methyl-3-
(nitromethyl)hexanal (6g) (A33D: 4mg, 2.3 10 2mmol, 60% and M45Y/F50A:
4mg, 2.3 10 2mmol, 60%) as a colourless oil. The 1H NMR spectroscopic data
of 6g (Supplementary Fig. 20) are in agreement with previously published data1,31.
Enantiomeric ratios were determined by GC using an Hewlett Packard (HP) chiral
20% permethylated b-cyclodextrin column (20m, 90 C isocratic, 1.5mlmin 1).
Flame ionization detection: tR: 3S-6g¼ 65.6min and 3R-6g¼ 67.5min led to the
following e.r. (3R:3S): racemic 6g¼ 50:50, 4-OT A33D 6gZ99:1 and 4-OT M45Y/
F50A 6g¼ 10:90 (Supplementary Fig. 26). The assignment of the absolute
conﬁguration was based on earlier reported chiral GC data31.
Derivatization of 6a and 6d–f for enantiomeric excess determination.
Acetalysation of 6a, 6d and 6e. The aldehyde functionality of 6a, 6d and 6e was
derivatized into a cyclic acetal, according to a literature procedure29,31. The
g-nitroaldehyde (5mg), ethylene glycol (25.6mg, 0.4mmol) and p-TsOH (5mol%,
0.2mg, 1.0 10 3mmol) were stirred in chloroform (800 ml) under a nitrogen
atmosphere for 1 day at room temperature, to yield the cyclic acetal of the
g-nitroaldehyde.
Esteriﬁcation of 6f. The aldehyde functionality of 6f was converted into a
methyl ester according to a literature procedure31. A solution of KH2PO4 (1mg,
7.35 mmol), NaClO2 (0.65mg, 7.2 mmol) and MeOH (75 ml, 16.3 mmol) in dH2O
(75 ml) were cooled down to 0 C, and 6f (5mg, 2.3 10 2 mmol) in acetonitrile
(75 ml) was added. After the addition of H2O2 (35% solution, 8.5 ml), the mixture
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was stirred at room temperature for 2 h. The pH was adjusted to 3 with 0.1M HCl
and saturated Na2SO3 solution (200 ml) was added. The product was extracted with
CH2Cl2 (3 1ml). The combined organic layers were washed with dH2O (500 ml),
dried on Na2SO4 and concentrated in vacuo. The residue was dissolved in toluene
(85 ml) and methanol (165 ml), and cooled down to 0 C. To this cooled solution,
trimethylsilyl diazomethane (20 ml, 40mmol, 2.0M in n-hexane) was added and
stirred at 0 C for 5min. The solution was stirred for additional 15min at room
temperature and the reaction quenched with concentrated AcOH. The solvents
were evaporated under vacuum, to yield methyl 3-(3-(cyclopentyloxy)-4-
methoxyphenyl)-4-nitrobutanoate.
Synthesis of nitroalkenes 5a–g. Nitroalkenes 5a–d were commercially available,
whereas 5e–g were synthesized and puriﬁed according to literature proce-
dures31,51–54.
Synthesis of racemic 6a–g. The racemic products 6a–g, which served as refer-
ences in the chiral-HPLC and chiral-GC analyses, were synthesized and puriﬁed
according to literature procedures31.
Structural analysis of M45Y/F50A. Crystallization of M45Y/F50A. Before
crystallization, puriﬁed enzyme was subjected to size-exclusion chromatography
using 20mM Tris-HCl (pH 7.5), containing 200mM NaCl, as an eluent. Fractions
containing 4-OT M45Y/F50A were pooled and concentrated to 10mgml 1.
Dynamic light scattering (DynaPro NanoStar, Wyatt Technology, CA) conﬁrmed
that the mutant existed as a hexamer in solution. Mass spectrometric analysis
indicated that the enzyme had been correctly processed with the N-terminal
methionine being cleaved off, leaving an exposed Pro-1. Attempts to reproduce the
previously reported condition of crystallization for wild-type 4-OT were unsuc-
cessful32. Therefore, a screening for new conditions was carried out at room
temperature in 96-well sitting-drop crystallization plates using various available
commercial screens. Drops (300 nl) were prepared with a nanodispenser
(Mosquito, TTP Labtech) by mixing protein and reservoir solutions at a 1:1 ratio.
The structure of M45Y/F50A was solved from a crystal that appeared in the
following crystallization condition: 0.2M sodium formate, 0.1M bis-tris propane
pH 8.5 and 20% PEG 3350 (w/v). Small crystals appeared after 3 days and grew to a
size of B100 75 75mm3 within 7 days. In addition, M45Y/F50A was co-
crystallized in the presence of acetaldehyde (3) and trans-b-nitrostyrene (5a) with
the aim of trapping a substrate or product-bound structure. A stock solution of
100mM 5a was prepared in DMSO. Before setting up drops, M45Y/F50A was
incubated with 50mM 3 and 10mM 5a for 30min. A screening was conducted to
ﬁnd new conditions as described above. The ﬁnal concentration of DMSO in the
drops was 5% (v/v). A single crystal with dimensions of 150 100 100mm3
appeared in a condition consisting of 0.1M PCTP buffer pH 7.0 and 25% (w/v)
PEG 1500 after 2 weeks.
Data collection and structure determination. Before proceeding with data
collection, crystals were transferred to a drop containing the mother liquor together
with 15% glycerol (v/v). Crystals were directly frozen in the liquid N2 stream of the
X-ray data collection equipment. Data sets for both crystals were collected in-house
at 110 K, using a Microstar rotating anode (Cu, wavelength of 1.5418Å) X-ray
source (Bruker AXS GmbH), coupled with Helios optics (Incoatec GmbH) and a
MAR345dtb detector (Marresearch GmbH). Diffraction data sets were processed,
scaled and merged using XDS55 and Aimless56. The M45Y/F50A structure
belonged to the space group C2, whereas the M45Y/F50A structure in complex
with substrate 5a crystallized in the P1 space group. A summary of the data
collection and model reﬁnement statistics is given in Supplementary Table 7.
Phaser57 from the CCP4 software suite58 was used to calculate initial phases.
The structure of wild-type 4-OT (PDB ID: 4X19)32 was used as a search model, to
perform molecular replacement for the M45Y/F50A structure. Subsequently,
multiple cycles of reﬁnement were performed using Refmac5 (ref. 59), together
with manual model building in COOT60 to improve the structure. The ﬁnal cycles
of reﬁnement were carried out in phenix.reﬁne available from the Phenix software
suite61. The coordinates and topology for 5a were generated using the PRODRG
server62. Target values for the bond lengths and bond angles, used in reﬁnement,
were derived from the crystal structure of 5a63, deposited in Cambridge Structural
Database (CSD entry: KANWOL10).
Crystal structure analysis. Calculation of Ca-backbone root-mean-square
deviation values and superpositions of structures were performed using the protein
structure comparison service at the European Bioinformatics Institute
(PDBeFold)64. PyMol (the PyMOL molecular graphics system, version 1.6;
Schrodinger, LLC.) was used to prepare ﬁgures and carry out analysis of the
structures. Molprobity, available as a part of the phenix.reﬁne module, was used to
validate the stereochemical quality of the models65. Coordinates for the free and
nitrostyrene-bound structure of M45Y/F50A have been deposited with the Protein
Data Bank (accession codes 5CLN and 5CLO, respectively).
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